Justin B Hill
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Justin B Hill has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Elena Grebenciucova
Department of Neurology, Northwestern University, Chicago, IL, USA
1 shared publication - Farrah Jasmine Mateen
Division of MS and Neuroimmunology, Davee Department of Neurology Northwestern University Chicago Illinois USA
1 shared publication - Horacio Chiong-Rivero
Department of Neurology, Anne Burnett Marion School of Medicine, Texas Christian University, Fort Worth, TX, USA
1 shared publication - Maya L. Mastick
Department of Neurology Massachusetts General Brigham Boston Massachusetts USA
1 shared publication
Latest Publications
- Open Access
- 9 September 2025
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 31 (11) , 1370-1380
Characterizing financial toxicity among people living with neuromyelitis optica spectrum disorder
Background: Financial toxicity (FT) and the social determinants of health (SDOH) remain underexplored in neuromyelitis optica spectrum disorder (NMOSD). Objective: To characterize FT in NMOSD and examine sociodemographic and clinical features. Methods: We conducted a convenience-sampled, cross-sectional, anonymous survey (08/2024–03/2025) of 124 U.S. adults. The COmprehensive Score for financial Toxicity (COST) was used to measure FT (lower COST = higher FT). Results: Seventy-five percent had a COST < 25 points, consistent with FT. In multivariable analysis, a higher attack frequency was associated with a 1.20-point lower COST score (95% confidence interval [CI] –1.90, –0.50), and each one-unit increase in disability, as measured by the Patient-Determined Disease Steps, was associated with a 0.80-point lower COST (95% CI –1.40, –0.20). Non-White race was associated with a 3.50-point lower COST (95% CI –5.80, –1.20), and double-seronegative antibody status with a 2.80-point lower COST (95% CI –5.00, –0.60). Mediation analysis suggested the effects of disability and race on FT are partially attributable to income. In exploratory models with attack count as the outcome, each one-point higher COST (lower FT) was associated with a 0.043-attack decrease (95% CI –0.081, –0.005). Conclusions: Financial toxicity is highly prevalent in NMOSD and associated with key clinical and sociodemographic features. There is a need for comprehensive NMOSD care models that address financial strain.
- 9 September 2025
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 31 (11) , 1370-1380
Open AccessCharacterizing financial toxicity among people living with neuromyelitis optica spectrum disorder
Background: Financial toxicity (FT) and the social determinants of health (SDOH) remain underexplored in neuromyelitis optica spectrum disorder (NMOSD). Objective: To characterize FT in NMOSD and examine sociodemographic and clinical features. Methods: We conducted a convenience-sampled, cross-sectional, anonymous survey (08/2024–03/2025) of 124 U.S. adults. The COmprehensive Score for financial Toxicity (COST) was used to measure FT (lower COST = higher FT). Results: Seventy-five percent had a COST < 25 points, consistent with FT. In multivariable analysis, a higher attack frequency was associated with a 1.20-point lower COST score (95% confidence interval [CI] –1.90, –0.50), and each one-unit increase in disability, as measured by the Patient-Determined Disease Steps, was associated with a 0.80-point lower COST (95% CI –1.40, –0.20). Non-White race was associated with a 3.50-point lower COST (95% CI –5.80, –1.20), and double-seronegative antibody status with a 2.80-point lower COST (95% CI –5.00, –0.60). Mediation analysis suggested the effects of disability and race on FT are partially attributable to income. In exploratory models with attack count as the outcome, each one-point higher COST (lower FT) was associated with a 0.043-attack decrease (95% CI –0.081, –0.005). Conclusions: Financial toxicity is highly prevalent in NMOSD and associated with key clinical and sociodemographic features. There is a need for comprehensive NMOSD care models that address financial strain.